Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations

Blood. 2020 Jun 11;135(24):2192-2195. doi: 10.1182/blood.2019003722.

Fabienne Lucas^{1

2}, Karylin Larkin^{1

2}, C Thomas Gregory^{1

2}, Shelley Orwick^{1

2}, Tzyy-Jye Doong^{1

2}, Arletta Lozanski^{1

2}, Gerard Lozanski³, Shrilekha Misra^{1

2}, Apollinaire Ngankeu^{1

2}, Hatice Gulcin Ozer⁴, Deepa Sampath^{1

2}, Shanmugapriya Thangavadivel^{1

2}, Selen A Yilmaz⁴, Kerry A Rogers^{1

2}, John C Byrd^{1

2

5

6}, Jennifer A Woyach^{1

2

5}, James S Blachly^{1

2

4}

¹ Division of Hematology, Department of Internal Medicine.
² The Ohio State University Comprehensive Cancer Center.
³ Department of Pathology.
⁴ Department of Biomedical Informatics.
⁵ Division of Pharmaceutics, College of Pharmacy, and.
⁶ Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH.

No abstract available

Publication types